The data show that the HER2-CD3-Fc mRNA-LNPs mediate robust and sustained expression of HER2-CD3-Fc bsAb in various types of target cells and induce highly potent T cell cytotoxicity and cytokine secretion against multiple HER2-positive tumor cells in vitro. This evidence concerns the gene ERBB2 and neoplasm.